Acura Pharmaceuticals, Inc. (ACUR)

Acura Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jan 21, 2025	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Market Capitalization	0	33	5	5	2	8
Market Cap Growth	615.81%	615.81%	-7.19%	102.71%	-71.22%	-7.41%
Enterprise Value	33	33	10	9	6	7
Last Close Price	0.00	0.50	0.21	0.23	0.11	0.40
PS Ratio	0.04	20.82	1.27	1.84	5.89	2.83
PB Ratio	0.37	182.83	-0.77	-1.03	-0.67	-311.06
P/TBV Ratio	182.83	182.83	-	-	-	-
EV/Sales Ratio	20.97	20.97	2.89	3.56	13.49	2.44
EV/EBITDA Ratio	-	-	294.93	-	-	-
Debt / Equity Ratio	1.12	1.12	-1.06	-1.27	-1.17	-99.78
Debt / EBITDA Ratio	-	-	179.11	-	-	-
Asset Turnover	1.20	1.20	1.66	1.13	0.12	0.46
Quick Ratio	0.43	0.43	0.14	0.98	0.21	0.49
Current Ratio	0.72	0.72	0.16	1.10	0.32	0.55
Return on Equity (ROE)	-	-	-	-	-	-983.04%
Return on Assets (ROA)	-58.46%	-58.46%	-2.62%	-19.22%	-72.44%	-50.98%
Return on Capital (ROIC)	-200.73%	-200.73%	-6.87%	-48.57%	-149.47%	-70.95%
Earnings Yield	-1324.81%	-2.70%	-26.57%	-77.04%	-158.97%	-67.65%
FCF Yield	-2.28%	-2.28%	-15.81%	-12.61%	-161.70%	-53.70%
Buyback Yield / Dilution	-75.75%	-75.75%	-20.96%	-26.36%	-32.97%	-33.98%
Total Shareholder Return	-75.75%	-75.75%	-20.96%	-26.36%	-32.97%	-33.98%

Source: S&P Capital IQ. Standard template. Financial Sources.